Learn if You Have a Claim Against St. Jude Medical, Inc.

St. Jude Symmetry Bypass Aortic Connector Comes Under Scrutiny Because of Numerous Complications Kahn Gauthier Swick is investigating claims that the St. Jude Symmetry Bypass Aortic Connector has been associated with a high occurrence of heart attacks, respiratory failure, and has been linked several deaths. The adverse effects associated with the St. Jude Symmetry Aortic Connector include graft narrowing, valve leakage, failed deployment, and occlusion. If you or a loved one has received a St. Jude Symmetry Aortic Connector, please contact Kahn Gauthier for more information.
Claimant Information

Are you submitting this information on behalf of yourself?	Yes No
Are you submitting this information on behalf of a family member?	Yes No
If yes, please provide: Name
Age
Relationship
Medical Information

Hospital & location where surgery was performed?
Was a St. Jude device used?	Yes No
Date of procedure?
Were there complications following the surgery?	Yes No
Please briefly describe any complications or other effects you believe were caused by the bypass device:
Are you presently covered by health insurance?	Yes No
Have you previously retained an attorney to represent you in this matter?	Yes No

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Chito-Trim, TurboTone, Impulse Female Herbal Blend/ Maximus Male Herbal Blend Marketers Settle Deceptive Advertising Suit for $750,000

The parties have reached a $750,000 settlement in an FTC administrative proceeding filed against dietary supplement marketer VisionTel Communications, LLC, on behalf of all persons who purchased Chito-Trim or TurboTone for weight loss, or Impulse Female Herbal Blend/ Maximus Male Herbal Blend for male and female sexual dysfunction. The action alleged that the marketers made deceptive advertising claims about these products in violation of federal consumer protection laws. Persons eligible to take part in the settlement should contact the prosecuting attorneys for more information.

Alleged Misrepresentations About Cerus Intercept RBC Systems Sends Stock Downwards

Several class actions have been filed against biotechnology company Cerus Corporation (Nasdaq: CERS) and certain of its officers and directors by stockholders who purchased the company's common stock between October 25, 2000, and September 3, 2003. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

Lawyers File Suit Against Drug Makers

Federal Judge Patti B. Saris in Boston claims Johnson & Johnson, Bristol-Myers Squibb Co., AstraZeneca Plc and GlaxoSmithKline Plc must face a class action lawsuit from consumers who say they were harmed by the way the companies charged for their drugs.

New Case Filed Against Lenox Hill Hospital, Details Not Yet Available

A class action lawsuit has been filed in the Southern District of New York against Lenox Hill Hospital. The case involves violations of the Employee Retirement Income Security Act (ERISA). No additional information about the substance of the allegations is available at this time. Classactionamerica.com will monitor this case and provide additional details as soon as they become available.

Avera Health Sued by Uninsured Patients Who Complain of Over-Charging

A class action lawsuit has been filed on behalf of uninsured patients who received and were billed for medical care by any hospital within the South Dakota based Avera Health network of hospitals. The suit contends that Avera billed its uninsured patients at rates far in excess of the rates employed for insured patients and that this practice was and is both discriminatory and illegal.

Gilead Sciences Allegedly Overstated Sales of HIV Drug Viread

A class action has been filed against pharmaceutical company Gilead Sciences, Inc. (Nasdaq: GILD) and certain of its officers and directors by stockholders who purchased the company's common stock between July 14 and October 28, 2003. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.